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Th17 cells have critical roles in mucosal defense and
aremajor contributors to inflammatory disease. Their
differentiation requires the nuclear hormone receptor
RORgt working with multiple other essential tran-
scription factors (TFs). We have used an iterative
systems approach, combining genome-wide TF
occupancy, expression profiling of TF mutants, and
expression time series to delineate the Th17 global
transcriptional regulatory network. We find that
cooperatively bound BATF and IRF4 contribute to
initial chromatin accessibility and, with STAT3,
initiate a transcriptional program that is then globally
tuned by the lineage-specifying TF RORgt, which
plays a focal deterministic role at key loci. Integration
ofmultiple data sets allowed inference of an accurate
predictive model that we computationally and exper-
imentally validated, identifying multiple new Th17
regulators, including Fosl2, a key determinant of
cellular plasticity. This interconnected network can
be used to investigate new therapeutic approaches
to manipulate Th17 functions in the setting of inflam-
matory disease.
INTRODUCTION
The vertebrate immune system, composed of numerous pheno-
typically well-defined cell types, is ideally suited for studying the
combinatorial action of transcription factors (TFs) and epigenetic
regulators whose target gene products confer unique cellularfunctions. TFs that are selectively expressed in subsets of
myeloid and lymphoid lineage cells have been designated
‘‘master regulators’’ if they are both essential and sufficient to
induce defined cell fates. It is becoming clear, however, that
networks of multiple TFs are required to achieve the full differen-
tiation programs (Mattick et al., 2010; Novershtern et al., 2011).
How such factors cooperate to determine specific programs
remains poorly understood.
CD4-expressing T lymphocytes are among the best-charac-
terized immune system cells (Zhu et al., 2010). They develop in
the thymus and acquire the potential to become T helper cells
that guide B lymphocytes to produce distinct classes of antibody
and carry outmultiple other effector functions; or they upregulate
the TF Foxp3 and become anti-inflammatory regulatory T cells
(Treg). T helper cells differentiate further in the periphery
following induction or activation of TFs in response to signals
from the T cell antigen receptor (TCR), cytokines, and other
ligands in the microenvironment. T helper effector subsets
include Th1 cells, which produce interferon-g and control infec-
tions with intracellular microbes; Th2 cells, which secrete IL-4,
IL-5, and IL-13 and are required for clearance of helminthes;
and Th17 cells, producers of IL-17A, IL-17F, and IL-22, which
protect mucosa from bacterial and fungal infection (Korn et al.,
2009). In addition, follicular helper T cells (TFH) provide B cells
with signals for immunoglobulin class switching and affinity
maturation (Crotty, 2011). CD4+ T cell subsets exhibit plasticity
but are considered distinct lineages based on expression of
TFs with properties of ‘‘master regulators.’’ Th1 cells are defined
by their expression of T-bet (Tbx21), Th2 cells by GATA3, Th17
cells by RORgt, and TFH cells by Bcl6. Effector T cells expressing
distinct subset-specific cytokines are common in vivo, although
cells with combinations of such cytokines are often observed.
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Treg cells can be mimicked in vitro by TCR stimulation and
combinations of defined cytokines. Genome-wide histone modi-
fications, chromatin accessibility, and occupancy by lineage-
specifying TFs have been studied in such models (Durant
et al., 2010; Kwon et al., 2009; Wei et al., 2009).
Th17 cells have critical functions in many autoimmune
diseases and in cancer (Korn et al., 2009). The orphan nuclear
receptor RORgt is required for the differentiation of Th17 cells
and for inflammatory diseases in mice. Its forced expression in
mouse and human T cells induces transcripts present in Th17
cells, including those coding for the key cytokines, for the
IL-23 receptor, and for the chemokine receptor CCR6 (Ivanov
et al., 2006; Manel et al., 2008). However, RORgt is not sufficient
to specify the full Th17 program, and other TFs, including STAT3,
IRF4, BATF, and IkBz, are required for induction of RORgt and
IL-17A in vivo and upon polarization in vitro by IL-6 and TGF-b,
with or without IL-1b and IL-23 (Bru¨stle et al., 2007; Okamoto
et al., 2010; Schraml et al., 2009; Yang et al., 2007). Multiple
other TFs are also involved in Th17 cell differentiation, including
c-Maf, Runx1, and Ahr (Bauquet et al., 2009; Veldhoen et al.,
2008; Zhang et al., 2008). RORa, which is closely related to
RORgt, can also contribute to IL-17 expression in the absence
of RORgt (Yang et al., 2008).
Investigation of TF functions in Th17 cell differentiation has
been limited to how single factors affect expression of a limited
number of targets (e.g., IL-17A). However, the Th17 differentia-
tion program extends beyond functions of individual cytokines,
as highlighted by studies showing Th17-mediated pathogenesis
in the absence of IL-17A and IL-17F (Codarri et al., 2011;
Leppkes et al., 2009). We therefore wished to examine how
multiple TFs regulate each other and their targets in order to
model a transcriptional network and identify critical factors in
Th17 cell differentiation. New regulatory interactions can be
found using genome-wide methods to learn networks from
time series and genetic and environmental perturbations
(Bonneau et al., 2007; Ernst et al., 2007; Faith et al., 2007;
Greenfield et al., 2010). Integrating multiple data types and
analytical methods for network inference using meta-analyses
(averaging over several data types and computational ap-
proaches) can leverage the complementary weaknesses and
strengths of each component to produce higher accuracy
networks (Marbach et al., 2012b). We have applied an integrative
approach, with meta-analysis of genome occupancy of multiple
TFs, RNA-seq of TF-deficient T cells, and immune cell transcrip-
tome data, to build a network model for Th17 cells. We find
in Th17 cell differentiation early cooperative binding of BATF
and IRF4 that governs chromatin accessibility and subsequent
recruitment of RORgt to regulate a select set of Th17-relevant
genes. We used the network model to identify additional
candidate genes that were in turn incorporated through an
iterative process and validated several genes critical in Th17
cell differentiation, including TFs that influence the expression
of > 2,000 genes. We found that the AP-1 family member
Fosl2 (confidently predicted to be a core Th17 factor) has
a key role in a mouse model of autoimmune disease, limiting
plasticity of T helper cell differentiation. In addition, loci that
are implicated in genome-wide association studies (GWAS) to
have roles in autoimmune disease were enriched in the Th17290 Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc.network. This analysis can therefore identify candidate genes
that serve as cogs in functional specialization of Th17 cells
and that have the potential to be valuable for new therapeutic
approaches.
RESULTS
TF Co-Occupancy Enriches for Functional cis
Regulatory Modules
We studied early Th17 cell specification events in a largely
synchronized population of naive CD4+ T cells that produce
IL-17 upon stimulation of the TCR in the presence of IL-6 and
low levels of TGF-b (Figure S1A available online). In this model,
cells receiving TCR stimulation alone serve as a nonpolarized
(Th0) control.
To assemble a high-resolution map of TF-DNA interactions in
Th17 differentiation, ChIP-seq was performed with antibodies
directed against STAT3, IRF4, BATF, c-Maf, RORg, and p300
with cells cultured in Th0 and Th17 conditions for 48 hr, when
Th17-specifying TFs are simultaneously expressed or active
(Figure S1B). Many high-confidence bound regions were
observed for each TF in Th17 conditions and for BATF and
IRF4 in Th0 cells with the cognate consensus binding motif
recovered for each (Figure S1C). TFs binding at key lineage-
associated loci (Il17a, Il17f, Il12rb1, Il1r1, Rorc) revealed a high
degree of colocalization in Th17 cells (Figures 1A and S1D), indi-
cating that these TFs occupy common cis regulatory regions and
highlighting their roles in integrating cytokine and TCR-derived
signals. In contrast, insulator-binding factor CTCF displayed
a distinct occupancy pattern.
To examine genome-wide TF binding patterns in Th0 and Th17
cells, we merged TF binding peaks with summits that clustered
in close proximity to each other (within 100 bp) to define putative
cis regulatory modules (pCRM; Figure 1B). In this manner,
162,113 significant TF peaks clustered into 83,138 unique
pCRMs, with distributions provided in Figure 1C. The clustered
heat map in Figure 1B displays TF binding significance for
TSS-proximal (± 5 kb) pCRMs and the associated fold change
in gene expression in Th17 versus Th0 cells for the nearest
gene (Figure 1B, right).
The pCRM clustering revealed that the most prominent signa-
ture was co-occupancy by all five TFs in Th17 cells and by IRF4
and BATF in Th0 cells (clusters 1 and 2, Figure 1B). This was not
a result of TF binding enrichment expected near the TSSs,
as 70% of the five-TF pCRMs localized to distal sites (>5 kb
from TSS; Figure S1E). Of note, BATF and IRF4 showed a
striking binding overlap regardless of occupancy by other Th17
TFs (clusters 3–6, Figure 1B). TF average binding significance
increased with pCRM order and was the highest at five-TF
pCRMs (Figure 1C), possibly reflecting enhanced accessibility
and/or cooperativity between factors at these regions. More-
over, strong RORgt binding was almost exclusively restricted
to five-factor pCRMs (clusters 1 and 2), suggesting that these
elements represent important regulatory domains for the inte-
gration of specification signals. Accordingly, these pCMRs
were proximal to loci showing differential expression in Th17
versus Th0 cells (Figure 1B, right). Nearly all (>99%) five-TF
pCRMs colocalized with the histone acetyltransferase p300
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Figure 1. Genome-wide Co-Occupancy of Th17 Lineage TFs
(A) ChIP-seq binding tracks for core TFs, p300, and CTCF at selected Th17 loci in Th0 and Th17 cells at 48 hr (visualized with IGV, Broad Institute).
(B) A clustered heat map of pCRM regions (rows) based on TF ChIP signals and the associated gene expression fold changes (FC) in Th17 versus Th0 cells.
A schematic illustration of the clustering approach is shown (top).
(C) Numbers of pCRMs with > 500 occurrences in Th17 cells (bottom) with associated distributions of TF ChIP p values (top). Box plots (top) show median (line),
25th–75th percentile (box) ± 1.5 interquartile range. Asterisk denotes that we observed significantly more pCRMs than expected by chance based on 10,000
simulations (p < 0.001).
(D) Luciferase reporter assay of enhancer activity for selected pCRM DNA regions in CD4 T cells cultured under Th2 and Th17 conditions. (y axis) Luciferase
activity relative to that of pGL4-minPwith aminimal promoter. (x axis) TF occupancy order of tested pCRMs (1 to 5 TFs); Il17a-5 and Il17a-19 serve as positive and
negative controls, respectively. Error bars represent SD of two experiments.
See also Figure S1 and Table S1.
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(Figure 1B), a factor for which occupancy can be predictive of
tissue-specific regulatory activity (Visel et al., 2009). Of note,
p300 binding in Th17 cells, though induced relative to Th0, was
not restricted to upregulated loci, whichmay reflect the contribu-
tion of inhibitory gene regulation by distal pCRMs.
To relate pCRMoccupancy to cis regulatory function, genomic
regions corresponding to pCRMs occupied by different numbers
of TFs were cloned upstream of a minimal promoter driving
a luciferase reporter and assayed for activity (Figure 1D). The
most active regions coincided with high-order occupancy, which
was also significantly more active in Th17 versus control Th2
cells. Thus, cis regions that integrate Th17 signals (4 and 5 TF
pCRMs) display lineage selectivity, and their combinatorial
occupancy increases the likelihood of activity. Together, these
findings support the view that core Th17 TFs function synergis-
tically and that shared regulatory targets of STAT3, IRF4,
BATF, c-Maf, and RORgt are likely enriched with key targets
for Th17 cell specification.
Cooperative Binding of BATF/IRF4 Complexes
Prepatterns Chromatin for Specification
The strong association between IRF4 and BATF occupancy in
both Th17 and Th0 cells suggested a regulatory interaction
between these factors. Indeed, in five-TF pCRMs, the binding
summits for IRF4 and BATF were more proximal than for any
other pair of Th17 TFs (Figure 2A), and BATF was uniquely
coimmunoprecipitated with IRF4 in a DNA-dependent manner
in Th17-polarized cells (Figure 2B), indicating that they form
a complex on DNA. Consistent with this, pCRMs co-occupied
by BATF and IRF4 lacked the interferon-stimulated response
element (ISRE) consensus but were enriched with two types of
dominant AP1-ISRE composite elements with AP-1 motifs adja-
cent to ISRE half sites (Figure 2C). As a similar motif structure
underlies cooperative binding of IRF4 and PU.1 (Eisenbeis
et al., 1995), we tested functional cooperativity of BATF and
IRF4 binding in a cellular context. We thus performed ChIP-
seq for each TF in Th0- and Th17-polarized cells genetically
deficient for the other TF. IRF4 and BATF occupancy was mark-
edly reduced in Batf and Irf4 mutant cells, respectively. The
effect was most significant at pCRMs occupied by IRF4 and
BATF in combination or with additional TFs when compared
to regions harboring single IRF4 or BATF peaks, where cooper-
ativity is not expected (Figure 2D). The dependence between
IRF4 and BATF was stronger at distal pCRMs, suggesting that
additional factors binding near promoters compensate for the
loss of either TF. Similar results were obtained in Th0 cells in
the absence of cytokine-induced factors (Figure S2A). Several
examples of this mutual binding dependency are shown (Figures
2E and S2B).
The cooperativity of IRF4 and BATF, paired with our finding
that cis regions bound by both TFs in TCR stimulation conditions
(Th0) exclusively acquire additional strong binding by STAT3,
RORgt, c-Maf, and p300 in Th17 cells (Figure 1B), suggests
that IRF4 and BATF function as pioneer factors in nucleating
binding of Th17 TFs upon cytokine-stimulated differentiation.
Consistent with this, occupancy of IRF4 and BATF is enriched
in the center of five-TF pCRMs (Figure S3A). To investigate this
hypothesis directly, we examined chromatin accessibility at292 Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc.regions co-occupied by all five TFs, using formaldehyde-
assisted isolation of regulatory elements sequencing (FAIRE-
seq). Deletion of IRF4 or BATF in Th0 or Th17 cells had little effect
on regions already accessible in naive cells, but most regions
with inducible FAIRE-seq signal exhibited marked reductions in
Irf4/ and Batf/ compared to WT cells in both Th17 and Th0
conditions (Figure S3B). Thus, in the absence of IRF4 and
BATF, regions normally bound by all five Th17 TFs are less
accessible, providing further evidence that IRF4 and BATF
remodel the chromatin landscape, potentially facilitating subse-
quent recruitment of TFs involved in regulating expression of
adjacent genes.
Consistent with IRF4 and BATF mediating accessibility, these
TFs also globally affect p300 occupancy, which was reduced in
IRF4- or BATF null Th17 cells (Figure S3C). STAT3 deficiency
also reduced p300 binding, but loss of RORgt resulted in
amuch smaller genome-wide effect (Figure S3C). The focal influ-
ence of RORgt was also reflected in occupancy of IRF4 and
STAT3 and the presence of H3K4me2 and H3K4me3, histone
marks associated with active transcription, in RORgt-deficient
Th17 cells (Figure S3D). Strikingly, few genes were dependent
on RORgt, as measured by more than 2-fold reduction (and p
value < 0.01) in both H3K4me3 at locus-linked pCRMs and
expression of the respective genes, namely Il17a, Il17f, Il23r,
Ccl20, Il1r1, Ltb4r1, which were known and novel targets
(2310007L2Rik, Furin, Fam124b, Tmem176a, and Tmem176b).
These findings are consistent with RORgt having a highly
specific regulatory footprint relative to initiator TFs that establish
broader changes in chromatin remodeling.
The Th17 Network Reveals Lineage Specification
by Combinatorial Regulation
Although it providesmechanistic insight, TF occupancy does not
sufficiently explain target gene regulation. We thus comple-
mented TF ChIP-seq (which finds direct targets) with RNA-seq
of TF wild-type versus knock-out (KO) Th17 cells (which finds
functional targets). ChIP p values for peaks falling within 10 kb
of the gene body were consolidated to a gene-wide p value,
and KO-RNA-seq p values were calculated based on target
gene differential expression. For each data set, p values were
mapped to rank-based scores from 0 (least significant) to 1
(most significant) and combined such that the integrated
ChIP + KO scores ranged from 0 to 2, with the highest-scoring
genes likely to be direct and functional targets. Rank-based
approaches have proved successful in similar settings (Madar
et al., 2010; Marbach et al., 2012a, 2012b; Prill et al., 2010)
(see Extended Experimental Procedures). High-confidence TF-
target interactions (score > 1.5; FDR < 10%) are visualized in
Cytoscape.
The resulting causal network captures known relationships
between core TFs, including Rorc activation by STAT3, IRF4,
and BATF (Bru¨stle et al., 2007; Schraml et al., 2009; Yang
et al., 2007) and further reveals feed-forward loops that reinforce
Rorc expression in response to TCR and cytokine signals (Fig-
ure 3A, box). Of note, there is high interconnectivity among
TFs, including positive feedback loops reinforcing expression
of initiator TFs BATF, IRF4, and STAT3, and a negative feedback
loop (c-Maf to BATF) that limits response. Conversely, RORgt
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Figure 2. Cooperative Occupancy by BATF and IRF4
(A) Proximal binding of BATF and IRF4. Distribution of the distance between ChIP peak summits for pairs of TFs in 5-TF pCRMs. Box plot is as shown in Figure 1;
points represent outliers.
(B) Coimmunoprecipitation of BATF, but not STAT3, with IRF4 in 48 hr Th17-polarized cultures. Ethidium bromide (EtBr) disrupts DNA-protein interactions. IP,
immunoprecipitating antibody; IB, immunoblotting antibody. Representative of two experiments.
(C) MEME-ChIP motifs identified in four subtypes of pCRMs as indicated. The AP-1 and ISRE consensus is recovered in regions singly occupied by BATF and
IRF4, respectively. A new AP-1-ISRE composite motif comprising an AP-1 site (TGA(C/G)TCA) adjacent to an ISRE half-site (GAAA; boxed region) is only
recovered at pCRMs occupied by BATF and IRF4. ISRE half-site orientation differs according to whether or not there is a 4 bp interval. The fraction of pCRMs for
which the motif is found is indicated.
(D) Genome-wide interdependence of IRF4 and BATF co-occupancy in Th17-polarized cells. Scatter plots display the fold change in ChIP-seq reads versus
significance. (Top) IRF4 inBatfWT versus KO. (Bottom) BATF in Irf4WT versus KO. Differences in ChIP-seq reads displayed for three relevant pCRM subtypes: (1)
BATF or IRF4 alone (green); (2) BATF and IRF4 (orange); and (3) BATF, IRF4, plus additional TFs (purple). Distribution of fold changes of WT versus KO occupancy
are displayed for proximal and distal pCRMs. Box plots are as shown in Figure 1C. RPM, reads per million. **p < 0.001, Kolmogorov-Smirnov test.
(E) Reciprocally reduced occupancy of BATF and IRF4 at the Cd28 locus in Th17-polarized cells deficient for IRF4 and BATF, respectively. ChIP-seq tracks were
normalized for library size.
See also Figures S2 and S3.does not participate in stabilizing positive feedback relationships
with inducing TFs, thus rendering its expression sensitive to
changing environmental signals. This is consistent with theneed for continuous STAT3 activation (McGeachy et al., 2009)
and the plasticity of the Th17 subset when cytokine conditions
are altered (Hirota et al., 2011; Lee et al., 2009).Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc. 293
AC
D
B
Figure 3. TF Combinatorial Interactions Specify the Th17 Lineage
(A) High-confidence regulatory edges (FDR < 10%; based on 10,000 simulations) focused on five core TFs identify direct (ChIP-seq) and functional (KO RNA-seq)
regulatory targets (visualized using Cytoscape). Boxed inset displays the regulatory interactions between core Th17 TFs. See network legend for visualization
scheme.
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Highly regulated nodes, defined by combinatorial regulation
by 4 or 5 core TFs, comprise many genes with critical lineage
modulatory and effector activity. These include key signature
genes (Il17a, Il17f, and IL23r), other relevant cytokines and
receptors (Il2, Il9, Lif, Il10, Il1r1, Il21, Il12rb1, Ebi3 [IL-27]
Ltb4r1, and Ccr6), and TFs (Rora, Hif1a, Runx1, and Foxo1)
(Korn et al., 2009). This indicates that other highly regulated
genes in diverse categories (e.g., ion transport, migration,
metabolism, and stress response) likely include novel Th17 regu-
lators or effectors (Figure 3B).
To assess the regulatory relationships between Th17 TFs, we
summarized the activating and repressing regulatory inputs for
each network gene in a clustered heat map (Figure S4A). Of
note, initiator TFs BATF, IRF4, and STAT3 regulate the largest
number of genes and impose complementary control of shared
targets, particularly in activation. This is most striking for
highly regulated Th17 genes (Figures 3C and S4B) and is
mirrored by the regulation of similar pathways (Figure 3D, i),
including helper T cell differentiation and activation, cytokine
signaling, metabolism, and oxidative/xenobiotic stress response
(some previously attributed to these TFs [Durant et al., 2010;
Kwon et al., 2009; Schraml et al., 2009]). Thus, together, initiator
TFs establish a broad and coherent transcriptional program in
Th17 cells.
c-Maf is generally appreciated as an activator of cytokine loci
(Ho et al., 1999). Unexpectedly, in Th17 cells, it functions mainly
as a negative regulator (Figures 3A and S4A), attenuating the
expression of proinflammatory loci (e.g., Rora, Runx1, Il1r1,
Ccr6, and Tnf) and globally repressing genes in pathways
regulated by other core TFs (Figure 3D, i). Of note, c-Maf does
positively regulate a few loci, several linked to attenuating
inflammation (e.g., Il9, Il10, Lif, and Ctla4). Together with the
recent description of c-Maf as an Il22 repressor (Rutz et al.,
2011), the global c-Maf target repertoire identifies an underap-
preciated general anti-inflammatory role for this TF.
RORgt, the key lineage specifier, functions as an activator and
a repressor within the network (Figure S4A). Of note, it either rein-
forces or antagonizes the coherent activation program initiated
by IRF4, BATF, and STAT3 (Figures 3C and S4B). Though RORgt
positively regulates many genes, it has a strong role at only
a small number of key Th17 loci (as defined above; Figures 3C
and S3D; see Figure S4C for the magnitude of RORgt depen-
dency). As a repressor, RORgt limits target expression, including
regulators of metabolism and quiescence (e.g., Il10, Hif1a,
Egln3, Foxo1, and Il7r) and alternative lineage fates (ll4ra and
Il12rb2) promoted by initiator TFs. In this regard, RORgt acts
as a modulator; its repressive activity is poorly correlated with
actual expression changes, with its repressed targets often
upregulated in Th17 relative to Th0 cells (Figures 3C and S4D).(B) Expanded view of highly regulated nodes with four to five core regulatory inp
(C) Regulatory interactions shared by STAT3, IRF4, BATF, and RORgt highligh
repression targets that are upregulated in Th17 cells; (reinforcement): activation ta
in RORgt KO differential expression and KO H3K4me3 ChIP.
(D) Targets for single TFs are enriched for pathways in multiple functional catego
selectively enriched for pathways related to T helper differentiation and effector fun
as a heat map of enrichment p values.
See also Figure S4 and Table S4.Thus, RORgt is essential in licensing the expression of a select
few loci, and elsewhere it functions as a rheostat to tune
mRNA levels to those of a Th17-specifying program.
Individual Th17 TFs regulate broad cellular functions (Fig-
ure 3D, i). When network targets were subdivided according to
the complexity of inputs (either 1, 2, 3, or 4/5 TF edges), pathway
analysis revealed a selective enrichment for genes involved in
helper T cell differentiation with increasing number of TF inputs
(Figure 3D, ii). Accordingly, nodes regulated by 4 or 5 TFs were
most enriched for genes highly differentially expressed in Th17
cells (Figure 3A, compare node color in center versus periphery).
Thus, although lineage TFs orchestrate the expression of genes
in similar pathways, lineage specificity is a product of high-order
combinatorial regulation.
Data Integration Allows for Discovery of Th17-Relevant
Genes
The ChIP- and KO-based network is accurate but lacks
regulatory information for other TFs with roles in Th17 cells. To
learn interactions for those TFs, we integrated into our pipeline
two other data sets (Figure 4A). The four data types are
designated: [C] ChIP-seq; [K] RNA-seq KO; [R] 155 helper
T cell RNA-seq experiments; and [I] public microarray data
spanning 167 immune cell types and conditions (Immunological
Genome Project; ImmGen) (Heng and Painter, 2008). In
addition to providing regulatory information for new TFs, R and
I can provide further support for interactions identified by
the other two data types (C and K). Z scores for putative TF
target regulatory interactions were individually assigned for
R and I using the Inferelator (Greenfield et al., 2010) and were
converted to rank-based scores, as above (ranging from 0 to 1),
to facilitate their integrationwith K andC (Extended Experimental
Procedures).
To validate our approach and evaluate complementarity of
data sets, we estimated the predictive power of the resulting
Th17 networks at recovering 74 literature-curated Th17-relevant
genes (Table S1). As key Th17 genes were strongly regulated
by multiple core TFs (Figure 3B), we reasoned that ranking
genes based on their summed scores over all five core TFs
would enrich for relevant target genes. We used two perfor-
mance metrics, the areas under precision recall (aucPR) and
under receiver operator curves (aucROC) that together provide
a balance between estimating the sensitivity (aucROC) and
accuracy (aucPR) of top-ranked predictions. Regardless of the
metric used, for each data combination, summed TF target
predictions (Figure 4B, bar) better identified Th17-relevant genes
than targets for individual TFs (Figure 4B, points in bar), high-
lighting the predictive power of leveraging combinatorial regula-
tion (also Figure S5A). Moreover, combining across data typesuts, grouped based on general functional categories.
ting different aspects of RORgt transcriptional function. (Attenuation) RORgt
rgets that are upregulated in Th17 cells; (essential) targets with a 2-fold change
ries (i). Targets of multiple TFs (increasingly regulated by 2, 3, or 4+5 TFs) are
ction (ii). Analysis performed using the ingenuity analysis tool (IPA) is presented
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Figure 4. Network Model Performance and
Validation
(A) Schematic for integration of four genomics and
systems data types (K, C, R, and I) using a rank
combined (RC) approach, resulting in the KC and
KCRI networks.
(B) Performance measured as aucPR values indi-
cating enrichment of literature-curated Th17
genes in networks derived from all possible data
combinations. Points indicate single TF predic-
tions (e.g., BATF/ target), and bars indicate TF
sum predictions (i.e., [BATF+IRF4+STAT3+MAF+
RORgt]/target). (Dotted line) Reference perfor-
mance for targets prioritized by differential
expression (Th17 versus Th0); (dashed line) for
random.
(C) Gene set enrichment analysis (GSEA, Broad
Institute) for the top-performing KCRI network. (i)
The ranked list of TF sum targets recovers Th17-
relevant genes with a maximal enrichment score
(ES) of 0.86 out of 1 (red line); random (gray line). (ii)
Vertical red lines indicate where in the ranked
list literature-derived genes were recovered. (iii)
Summed TF score distributions for KCRI (red line)
and random (gray line).
(D) The KCRI network selectively recovers GWAS
SNP-linked genes for Th17-implicated inflamma-
tory diseases. Recovery of SNP-associated
disease genes is measured in terms of aucPR for
TF sum predictions (gray bars) and single TF
predictions (points).
(E) Core TF networks for genes associated with
GWAS of Crohn’s disease and type 2 diabetes.
The KCRI network recovered 24 out of 80 Crohn’s
disease genes (p = 107) and 9 out of 84 type 2
diabetes genes (p = 0.29). Network display is as in
Figure 3. p values calculated by Fisher’s exact
test.
See also Figure S5 and Tables S1 and S4.resulted in higher quality networks (note the performance
increase with data integration; Figures 4B and S5A). This is
true for both K + C, which produces a smaller (core-TF-centered)
but accurate network, and for R + I, which generates a
more comprehensive (more than 170 differentially expressed
TFs) but less accurate model. Thus, combining data as in
K + C + R + I provides additional network information without
compromising the K + C network accuracy, leading to a 3-fold
performance boost at finding relevant Th17 genes over the
conventional differential expression list (Figure 4B, dotted line).
Moreover, the nonparametric rank-based scheme is better
suited for combining data than an alternative parametric Fisher
method for combining p values (Figures S5C and S5D).
We further characterized the predictions of the top-performing
KCRI network using gene set enrichment analysis (GSEA; Fig-
ure 4C). Literature-curated genes were highly enriched as
top predictions (60 of 74 total), ranking many more putative296 Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc.Th17-relevant genes with comparable
KCRI scores (1,328 of 22,000 total).
The wealth of GWAS information for
diseases in which Th17 cells are impli-cated allowed us to judge the relevance of our mouse Th17
network for human disease (Hindorff et al., 2012). Loci linked
to SNPs associated with ulcerative colitis (UC), Crohn’s disease
(CD), multiple sclerosis, psoriasis, and rheumatoid arthritis were
significantly enriched in the core (KCRI) Th17 network (Figures
4D, 4E, and S5B). This is in striking contrast to diseases with
enrichment scores expected by chance (Alzheimer’s disease
and schizophrenia) and other inflammatory diseases in which
Th17 cell involvement is not established (e.g., type 2 diabetes
and systemic lupus erythematosus [SLE]). Of note, for those
diseases with strong links to Th17 function, GWAS-associated
genes aremore highly regulated by the core Th17 TFs (Figure 4E),
and TF sum scores (Figure 4D, bars) better recovered GWAS loci
relative to individual TFs (Figure 4D, points). This strongly
supports the notion that synergy between the five core Th17
TFs is also relevant for function of the Th17 lineage in human
disease.
Network Analysis Identifies Modulators of the Th17
Program
Our validations revealed that highly regulated targets of the KCRI
network can be exploited to identify Th17-relevant effector
genes. However, early response regulators that function
upstream of or in parallel with core TFsmay not be captured (Fig-
ure 3A). To address this, we used an independent Inferelator-
derived ImmGen network (I) to predict new TFs that demonstrate
significant target overlap with the five core TFs (KC network; see
Extended Experimental Procedures); a similar method was
proven successful (Carro et al., 2010). Accordingly, 26 candidate
Th17 TFs were prioritized that either: (1) were top-scoring KCRI-
network-regulated genes (90th percentile) or (2) showed signifi-
cant overlap between their predicted targets and targets of the
five core TFs. The latter TF enrichment analysis identified all
core TFs as top hits and several known Th17 regulators (see
full list in Table S2), including RORa, AHR, RBPJ, and TBX21
(Alam et al., 2010; Veldhoen et al., 2008; Yang et al., 2008).
To assess the effects of prioritized TFs on Th17 cell differenti-
ation, we performed gain- and loss-of-function experiments.
Among the 16 TFs overexpressed in CD4+ T cells by retroviral
transduction, several had a significant effect on the percentage
of IL-17A+ cells generated, including Ets factor Etv6, Ncoa2,
Smad3, Hif1a, Skil, and Trib3 (Figures S6A and S6B). Most
striking was the AP-1 family member Fosl2, the top-predicted
factor in the TF enrichment analysis (Table S2), whose overex-
pression significantly reduced the number of IL-17A-producing
cells.
In a complementary approach, we performed siRNA-medi-
ated knockdown (KD) experiments for 14 candidate TFs with
siRNA pools electroporated into activated CD4+ T cells sub-
jected to Th17-polarizing conditions. Reductions in target TF
mRNAs were similar to those observed with siRorc, which effec-
tively reduced RORgt (Figures S6C and S6D), its targets (Il17a/f,
Il23r, and Il22), and Th17 differentiation (Figures 5A, 5B, and
S6C). Strikingly, six TF KDs significantly altered IL-17A produc-
tion relative to a nontargeting control, without affecting the
concomitant generation of Foxp3+ iTreg cells. These included
Etv6, Nfatc2, Bcl11b, Crem, and regulators of chromatin remod-
eling (Satb1 and Kdm6b [Jmjd3]) (Figures 5A and 5B). Thus, the
network method prioritized and made accurate predictions
about genes that influence expression of IL-17A, a key compo-
nent of the Th17 phenotype.
To assess factor influence on the broad Th17 program, we
performed RNA-seq of TF KD cultures. Global pathway analysis
for TF-dependent genes identified distinct factor-related path-
ways yet showed a striking convergence in enrichment for genes
involved in T helper cell differentiation/function for all factors
except Sirt2 and a non-TF control, Ccr6 (Figure 5C). Indeed,
TF-dependent loci comprise a variety of helper T cell effector
or lineage-specializing genes (Il4, Ifng, Gata3, Foxp3, Tbx21,
Il22, Il1r1, Il23r, Il10, Il24, Il9, andCcl20) (Figure 5D). Of particular
interest, Bcl11b influenced the expression of a broad set of
helper T cell modulatory genes, suggesting a key regulatory
role in subset diversification. Similarly, Jmjd3, a lysine K27
demethylase and known T-bet partner (Miller et al., 2010), dis-
played a marked influence on the activation of multiple Th17-
expressed cytokines, suggesting that it may partner with coreTh17 TFs. Indeed, Jmjd3 shares many direct targets (KD + C)
with RORgt and STAT3 (Figure S6E). Taken together, the results
show that the network model identifies many candidate modula-
tors of the Th17 program.
Fosl2 Is a Core Component of the Th17 Specification
Program
The AP-1 family TF Fosl2 was the highest-ranking candidate to
coregulate targets with core TFs (Table S2). We interrogated
its role in helper T cell differentiation and function using mice
with conditional deletion of Fosl2 in T cells (Fosl2fl/fl CD4-Cre).
Fosl2-deficient CD4+ T cells could be polarized in vitro into
Th1, Th2, Th17, or iTreg cells, but notably, cytokine production
was dysregulated (Figures 6A and S7A). Fosl2 null Th17 cultures
weremarkedly increased for IL-17A-producing and atypical Fox-
p3+IL-17A+ cells. There was also low-level derepression of Il17a
in mutant Th1 and Th2 cells, consistent with Fosl2 function as an
Il17a repressor (Figures S6A, S6B, and S7A). Fosl2 deficiency
also enabled IFNg production in Th17 and Th2 cultures,
particularly when Th17 cells were subsequently exposed to
Th1-skewing conditions (Figures S7A and S7B).
We next examined the role of Fosl2 in the Th17-dependent
disease model experimental autoimmune encephalomyelitis
(EAE), which mimics the CNS pathology in multiple sclerosis.
Fosl2fl/fl CD4-Cre mice had significantly attenuated disease
severity compared to wild-type controls (Figure 6B). Analysis
of spinal cord infiltrates at 21 days postimmunization revealed
reduced CD4+ T cells but similar percentages of IL-17A, IFNg,
and GM-CSF producers in mutant mice. Strikingly, the Fosl2-
deficient cytokine-producing T helper cells also expressed the
TF Foxp3, which specifies the Treg program (Figures 6B and
6C). Consistent with our in vitro observations (Figure 6A), these
findings suggest Fosl2 as a key regulator of T helper lineage
plasticity, particularly under inflammatory conditions.
To gain insight into Fosl2 function, we identified its direct
targets using K + C analysis. Consistent with previous studies,
Fosl2 both activates and represses target loci (Wagner and Eferl,
2005). It attenuates expression of Th17 signature genes in
addition to Il17a (Il17f, Ccl20, Ccr6, Il1r1, and Batf) and of Th1
regulatory loci (Tbx21, Il18r1, Il18rap, and Il2), suggesting a
role in controlling inflammatory responses and preventing Th1
specification (Figure 6D). Conversely, Fosl2 also promotes the
expression of genes that drive Th17 maintenance and survival
(Il6ra, Il-23r, Il12rb1, il7r, and Il21) and helper T cell diversification
or function (Il4ra, Il12rb2, Il2ra, Il10ra, Ltb4r1, Smad3, and Hif1a)
(Figure 6D). These loci are also targeted by the five core TFs,
indicating that Fosl2 modulates the lineage identity and func-
tional programs regulated by core Th17 TFs.
In light of the dominant regulation by AP-1 factors in the Th17
lineage, it was interesting to observe a high degree of overlap in
occupancy by Fosl2 and BATF (Figure 6E), suggestive of an
antagonistic relationship between them. This may be mediated
by direct competition for the same binding sites (Figure S7C)
and enhanced by direct transcriptional repression of Batf by
Fosl2 (Figure S7D). Thus, as predicted, Fosl2 is a highly intercon-
nected component of the core Th17 specification program. This
is in contrast to Hif1a, a recently identified regulator of Th17 cells
(Dang et al., 2011), which was not predicted to share a significantCell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc. 297
Figure 5. Identification of Th17 Regulators
(A) siRNA knockdown screen of candidate TF function in Th17 differentiation. Percent of IL17A-producing cells relative to the control siRNA condition for
knockdown cultures analyzed at 24 hr of Th17 polarization. Error bars represent SD of two experiments conducted in triplicate. *p < 0.05 and **p < 0.01, t test.
(B) Flow cytometric analysis for Th17-polarized cells transfected with siRNAs for the indicated gene targets.
(C) Shared and unique functions of Th17 TF regulators. Heat map of ingenuity pathway enrichment (IPA, p < 0.01) for candidate TF-dependent genes.
(D) TF candidates influence the expression of immune-modulatory genes. Heat map of log2 fold change in expression of T helper signature genes in the siRNA
knockdowns relative to nontargeting control for 24 hr Th17 polarization cultures.
See also Figure S6 and Table S2.number of targets with core TFs (Table S3) and is not as intercon-
nected as Fosl2 (Figure 6D).
Visualization and Exploration of the Extended KCRI
Th17 Network
The final KCRI network comprises 173 differentially expressed
TFs controlling 3,679 genes with 19,000 interactions. The298 Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc.subset of this network surrounding regulators based on ChIP-
seq and KO data is more accurate but is limited (this network
has seven TFs controlling 2,218 genes, with 4,237 edges). To
facilitate interrogation of the Th17 transcriptional network by
the scientific community, we provide access to the primary
data (see Table S3 and Supplemental Information), the networks
(KC and KCRI), and analysis tools at http://th17.bio.nyu.edu.
DISCUSSION
Th17 cells exert critical functions in immune defense at mucosal
barriers and are implicated as contributors to multiple autoim-
mune diseases (Korn et al., 2009). Since the discovery of Th17
cells, multiple TFs involved in the production of IL-17A and in
inflammation have been described, but little was known of how
they collaborate in the global transcriptional program governing
Th17 specification and function. Here, we aimed to accurately
define how Th17 TFs integrate functionally to execute this
program and created a useful network model that can be ex-
ploited to uncover lineage regulators, effectors, and potential
therapeutic targets (Figure 7). To achieve this, we used a culture
system for Th17 differentiation to build a transcriptional network
model based on combinations of data sets and analytical
approaches and determined its performance using both compu-
tational and experimental validations, testing the role of pre-
dicted regulators in vitro and in a disease model of inflammation.
Our combined computational and experimental approach
allowed for iteration between the generation of a data integrative
network and follow-up investigation of individual genes, and,
hence, for continuous network refinement (Figure 4A). This
work provides a clear experimental design and analysis frame-
work that can be adopted for other cell lineages in the immune
system and elsewhere.
Dynamics of TF Function in the Specification
of CD4+ T Cells
Transcription initiation at sites occluded by nucleosomes and
high-order chromatin structure requires mechanisms for making
specific regions accessible to appropriate regulators (Zaret and
Carroll, 2011). In TCR-activated CD4+ T cells, BATF and IRF4
bind cooperatively to sites throughout the genome. In the pres-
ence of Th17-polarizing cytokines, STAT3, c-Maf, and RORgt
are recruited to many of the same sites. Chromatin accessibility
analysis suggests that BATF/IRF4 complexes pioneer the
access of other TFs that further specify functional subsets.
Indeed, BATF and IRF4 have critical roles in multiple Th cells
(Bru¨stle et al., 2007; Ise et al., 2011; Rengarajan et al., 2002;
Schraml et al., 2009). As these TFs are upregulated in Th0 cells,
it is interesting to speculate that pioneering function provides
the T cell with plasticity to differentiate in multiple directions, de-
pending on the cytokine environment. Thus, whereas TGF-b and
STAT3-activating signalswould recruit STAT3/RORgt to a subset
of BATF/IRF4 binding sites, Th1 or Th2 signals may recruit
STAT1/T-bet or STAT6/GATA-3 to others. It will be of interest
to compare the global distribution of BATF, IRF4, and lineage-
specifying TFs in Th1 and Th2 cells.
Fosl2 is a negative regulator of IL-17A. Thus, the finding that
Fosl2-deficient mice had a reduced inflammatory response in
the EAEmodel was unexpected. Thismay reflect the requirement
for Fosl2 for expression of key loci supporting Th17 cell mainte-
nance. The result may also be explained by derepression of
Foxp3 in inflammatory T cells producing IL-17A, IFNg, and GM-
CSF, which may be mediated, in part, by reduced expression of
Hif1a—a Foxp3 inhibitor—in Fosl2-deficient T cells (Dang et al.,
2011). Foxp3+ T helper cells that produce effector cytokines have
been described in humans and have been shown to have regula-tory activity (Voo et al., 2009). Hence, reduced disease scores
in Fosl2 deficiency may be due to increased activity of Treg-like
cells infiltrating the CNS. Fosl2-deficient T cells also derepress
T-bet and IFNg, suggesting that Fosl2 serves as a brake, binding
to sites otherwise occupied by BATF and IRF4 to prevent ex-
pression. Indeed, Fosl2 occupancy overlaps with that of BATF
and IRF4 in Th0 and Th17 cells, where it likely competes for
AP-1 sites (Figure 7). Thus, Fosl2 is a highly integrated regulator
of T helper cell lineage identity, functioning to limit plasticity of
Th17 cells by repressing Th1 and Treg transcriptional programs
potentially by balancing the activity of BATF/IRF4 at key loci.
Our analysis also highlights that regulation of a single cytokine,
i.e., IL-17A, does not reflect broad functions of the controlling
TFs. A global perspective in the context of amulti-TF causal regu-
latory network aids in deciphering the role of individual factors.
RORgt has been described as a ‘‘master regulator’’ for the
Th17 program, yet it has a surprisingly small regulatory footprint.
RORgt deficiency had limited effects on p300 recruitment and
H3K4methylation, suggesting that it lacks a major role in remod-
eling its regulated loci. However, a handful of loci were highly
dependent on RORgt for these early inductive events (Figure 7);
what distinguishes this selectivity remains to be uncovered. This
focal mode of regulation, coupled with a generalized program
upon which RORgt functions to tune expression, is consistent
with the plasticity of Th17 cells, suggesting that expression
and chromatin state at key Th17 loci might be amenable to rapid
change depending on cytokine environment. The lack of stabi-
lizing positive feedback of RORgt to initiators may permit such
T helper program switching. Moreover, though RORgt attenu-
ates the expression of regulators of alternative Th subsets
(il4ra, il12rb, and Tbx21), these loci are nevertheless expressed.
Thus, RORgt is not a prototypical ‘‘master’’ regulator that func-
tions to ‘‘lock in’’ lineage programs. This renders RORgt an
exceptional drug target, as therapeutic intervention would not
be expected to perturb the generic regulatory programs shared
by other cell types.
A Highly Predictive Th17 Cell Network Model
The iterative approach applied here was successful in uncover-
ing important aspects of Th17 biology, generating a model that
captures most of the previously identified Th17-relevant genes
among the top candidates and predicting many more with equal
confidence. Among these, several TFs and chromatin modifiers
were shown to affect Th17 differentiation or the expression of
immune-modulatory genes, including Bcl11b, Etv6, and Jmjd3.
Although we focused on the top-predicted TF Fosl2, we expect
that many more candidates will be pertinent to Th17 biology. We
anticipate the network model presented herein to be a highly
useful tool for exploration and for generation of new hypotheses.
Although the Th17 network largely models in vitro differentia-
tion, it is nonetheless likely to be relevant for in vivo Th17 cell
functions. Indeed, Fosl2 mutant T cells were compromised in
effector function in an autoimmunity model, and similar pheno-
types were reported in mice deficient for many top-scoring
network genes. Moreover, the network is selectively enriched
for genes with orthologs that harbor SNPs associated with
human inflammatory diseases linked to Th17 cell-mediated
pathology, such as Crohn’s disease and psoriasis. GWASCell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc. 299
Figure 6. Fosl2 Regulates Loci Critical to Lineage Identity and Function
(A) Fosl2 negatively regulates IL-17A expression. Flow cytometric analysis for naive Fosl2WT and KOCD4 T cells cultured as indicated for 3 days. Representative
of four experiments.
300 Cell 151, 289–303, October 12, 2012 ª2012 Elsevier Inc.
Figure 7. Model for Th17 TF Functions
during Lineage Specification
Functions of the core TFs and a selection of newly
identified TFs in regulating expression of general
T-helper-cell- and Th17-cell-associated genes.
BATF/IRF4 complexes, transcriptionally induced
following TCR signaling, mutually activate the
expression of a large set of target genes, together
with STAT3. RORgt drives expression of a small
subset of key Th17 genes and modulates the
expression of genes activated by initiator TFs,
BATF/IRF4/STAT3. Fosl2 restricts the expression
of genes required for alternate CD4+ differentiation
programs. c-Maf functions as a general repressor.
Regulatory hubs include loci that receive a high
level of input from Th17 TFs and are enriched for
genes that are critical for Th17 differentiation and
function.studies, while facilitating the identification of genes involved in
complex diseases involving multiple cell types, are often difficult
to translate into biological hypotheses amenable to investiga-
tion. However, our analysis identified several GWAS-implicated
genes as candidate Th17-specific mediators of pathogenesis
(e.g., PTPN22, LIF, and KLF6) and may be used to implicate
Th17 cells in the etiology of particular conditions. Deconvoluting
GWAS data by leveraging the information from accurate and
comprehensive transcriptional regulatory networks to provide
cellular context, reveal functional epistasis, and prioritize genes
of potential medical importance will likely prove to be a powerful
approach in uncovering disease mechanisms and developing
new diagnostic and therapeutic tools (Califano et al., 2012).
Taken together, this body of work is an excellent example of
how the power of systems biology can be harnessed to answer
a specific large-scale biological question, thus providing a vali-
dated paradigm for similar undertakings.
EXPERIMENTAL PROCEDURES
For full details of experimental and computational approaches, see the
Extended Experimental Procedures and Extended Computational Methods.(B) Conditional deficiency of Fosl2 in CD4 T cells reduces the severity of EAE. (To
alleles (*p < 0.05 and **p < 0.01, t test). (Bottom) Total numbers or percentages of
T cells are defined as Foxp3. Representative of two experiments.
(C) Predominance of cytokine-producing Foxp3+ cells in mice during EAE. Flow cy
lymph nodes of mice on day 22 post-EAE induction. Plots were gated on CD4+C
(D) Combinatorial core TF targets involved in T cell specification are highly regula
manually to account for Tbx21 with ChIP peaks outside of the set boundaries (1
(E) The clustered heat map of Fosl2 and core TF occupancy reveals that the bin
See also Figure S7.In brief, naive CD4+ T cells were purified from lymph nodes and spleen of
wild-type mice or TF KO mice. The cells were cultured under Th0 and
Th17 conditions and were processed for ChIP-, RNA- and FAIRE-seq. The
analysis pipeline included dedicated methods for learning from individual
data sources.
ACCESSION NUMBERS
The GEO accession number for the full data set (ChIP-seq and RNA-seq) is
GSE40918.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
Extended Computational Methods, seven figures, and five tables and can be
found with this article online at http://dx.doi.org/10.1016/j.cell.2012.09.016.
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